Calculate Your Salary Ranking
Home > CyDex Pharmaceuticals Salary

CyDex Pharmaceuticals Salary
  • 89
  • 23
  • 64

CyDex Pharmaceuticals average salary is $82,575, median salary is $82,575 with a salary range from $79,700 to $85,450.
CyDex Pharmaceuticals salaries are collected from government agencies and companies. Each salary is associated with a real job position. CyDex Pharmaceuticals salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Total 1 CyDex Pharmaceuticals Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More Info
Chemist 79,700-85,450 Shawnee Mission, KS, 66214 2010 CyDex Pharmaceuticals Chemist Salaries (2)
CyDex Pharmaceuticals Shawnee Mission, KS Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.    How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address
Recent CyDex Pharmaceuticals Salaries (February 23, 2017)
Assistant Professor University of Oklahoma $42,860 Norman, OK, 73019 01/05/2015
General OMRON $65,998 Houston, TX, 77001 09/07/2015

CyDex Pharmaceuticals salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
CyDex Pharmaceuticals Information
  • CyDex Pharmaceuticals
  • Industry: BioTech/Drugs
  • City: Lenexa, KS
  • CyDex, Inc., a privately owned company in suburban Kansas City, is applying innovative drug delivery technologies to enhance the usefulness of new or existing medications. CAPTISOL(R), the company's premier product, is a patented drug delivery vehicle that CyDex has licensed to leading pharmaceutical and biotechnology companies. CyDex has collaborations with Allergan, Inc.; Bristol-Myers Squibb; Daiichi Pharmaceutical Co., Ltd., of Japan; OSI Pharmaceuticals, Inc.; Pfizer, Inc.; Pfizer Animal Health; PTC Pharma AG, of Switzerland; and Suntory Ltd., of Japan. CyDex also is developing its own portfolio of CAPTISOL-Enabled(TM) drug candidates.